Contact Us
CME Login
Join Our Mailing List

Archive

Sort by Expiration Date:
Filter:
Search

Archive

JOIN OUR MAILING LIST
Sort by Expiration Date:
Filter:

Avoiding Delayed Diagnosis in Patients with Amyotrophic Lateral Sclerosis: What Can You Do to Improve the Patient Journey to Specialist Care?

This “situation room” activity allows learners to practice making clinical decisions in the management of patients with ALS. Learners will view simulated 2D interactions between patients and their physicians and use information from the patients’ electronic charts to decide the next best course of action. Topics covered in this activity include assessment of disease severity and quality of life, intensification of treatment, and recognizing adverse events.

Release Date: November 22, 2021
Expiration Date: November 22, 2022

Learn More & View Event »

Oncology Nurses Quality Improvement Series

This case-based online activity will cover the diagnosis, treatment, and management of patients with cancer who are treated or eligible for treatment with immunotherapy, as well as, the treatment and management of patients with HER2-negative breast cancer.

Release Date: November 17, 2020
Expiration Date: November 17, 2021

Learn More & View Event »

COVID-19 Frontline TeleECHO Series: Evolving Strategies in the Management and Prevention of COVID-19

The COVID-19 FRONTLINE TeleECHO series provides a comprehensive and up-to-date perspective on the ever- changing management of patients with COVID-19. Each TeleECHO session features in-depth case studies to encourage retention of the lessons and provide new perspectives on the management of patients during the COVID-19 pandemic. The case studies will focus on different issues facing clinicians, such as the management of severe and critically ill patients, the treatment of pulmonary and extrapulmonary manifestations, and the impact of comorbidities on treatment.

Release Date: November 20, 2020
Expiration Date: November 20, 2021

Learn More & View Event »

An Animated Whiteboard Online View of Biological Agents for the Treatment of Systemic Lupus Erythematosus

This activity targets healthcare gaps related to the identification and understanding of potential therapeutic targets for treating systemic lupus erythematous (SLE), impacting SLE management and potential utilization of targeted treatment.

  • By addressing these gaps, you can assess whether your treatment approaches to SLE include considering the use of biologic agents in addition to corticosteroids and immunosuppressants, allowing modifications of treatment approaches to help close these gaps.
  • Expert discussion will guide you in identifying potential pathophysiologic targets, deciding whether treatment with biologic agents is indicated, and utilizing clinical trial data and algorithms to guide treatment approaches based on disease severity.
  • You will also be immersed in dynamic animations utilizing a whiteboard platform to memorably highlight key points related to disease pathophysiology as it relates to the role of interferons and biologic agents targeting the interferon alpha receptor.

Release Date: December 17, 2020
Expiration Date: December 17, 2021

Learn More & View Event »

COVID-19 Frontline – A New Light in the Darkness: Therapies Recently Granted Emergency Use Authorizations for Patients with COVID-19

This program will explore the use of agents recently granted emergency use authorization for the management of COVID-19. Clinicians will learn about the mechanism of action of monoclonal antibodies against COVID-19, how to identify patients who are at risk for developing severe COVID-19, and discuss best practices on incorporating these agents into clinical practice to prevent the development of severe COVID-19 in recently diagnosed patients. This activity will also explore the use of baricitinib in combination with remdesivir for patients hospitalized with COVID-19 and provide guidance on how to select patients who would benefit from this therapy.

Release Date: December 23, 2020
Expiration Date: December 23, 2021

Learn More & View Event »

Reducing the Burden of Atrial Fibrillation: A Whiteboard Animated Tour of Antiarrhythmic Drugs for Cardiologists

This online activity targets healthcare gaps related to the treatment and management of atrial fibrillation (AF), impacting outcomes through guidelines and best practices, appropriate antiarrhythmic use and shared decision-making.

  • By addressing these gaps, you can assess whether your approach to AF management through utilization of current treatment guidelines and strategies for shared decision making – could be modified to help close these gaps.
  • Expert discussion will guide you in analyzing and identifying appropriate candidates for antiarrhythmic intervention, utilizing clinical trial and real-world data on efficacy and safety to affect patient outcomes.
  • You will also be immersed in dynamic animations utilizing a whiteboard platform to memorably highlight key points related to antiarrhythmic mechanisms of action and consequences related to interactions with other cardiovascular agents.

Release Date: January 4, 2021
Expiration Date: January 4, 2022

Learn More & View Event »

COVID-19 Frontline: Emerging Monoclonal Antibody Therapies and Vaccines for COVID-19: How They Work and When to Use Them

This COVID-19 FRONTLINE Whiteboard series will explore the role of emerging monoclonal antibody therapies and vaccines in managing the COVID-19 pandemic. Each module will focus on clinical trial data and aid clinicians in identifying patients who would benefit from therapy.

In this module, we will compare the mechanism of action of monoclonal and polyclonal antibodies and evaluate clinical trial evidence on the efficacy and safety of these therapies for the management of COVID-19.

Release Date: February 2, 2021
Expiration Date: February 2, 2022

Learn More & View Event »

COVID-19 Frontline: Emerging Monoclonal Antibody Therapies and Vaccines for COVID-19: How They Work and When to Use Them

This COVID-19 FRONTLINE Whiteboard series will explore the role of emerging monoclonal antibody therapies and vaccines in managing the COVID-19 pandemic. Each module will focus on clinical trial data and aid clinicians in identifying patients who would benefit from therapy.

In this module, we will review the mechanism of action of monoclonal antibody therapies and vaccines for the prevention and treatment of COVID-19, and assess the efficacy and safety of these emerging therapies.

Release Date: February 2, 2021
Expiration Date: February 2, 2022

Learn More & View Event »

COVID-19 Frontline: Emerging Monoclonal Antibody Therapies and Vaccines for COVID-19: How They Work and When to Use Them

This COVID-19 FRONTLINE Whiteboard series will explore the role of emerging monoclonal antibody therapies and vaccines in managing the COVID-19 pandemic. Each module will focus on clinical trial data and aid clinicians in identifying patients who would benefit from therapy.

In this module, we will investigate the risk of therapy failure due to SARS-CoV-2 mutation with single and dual monoclonal antibody therapies.

Release Date: February 2, 2021
Expiration Date: February 2, 2022

Learn More & View Event »

Accurate Diagnosis and Effective Management of Children with Growth Hormone Deficiency: What Can You Do to Improve Patient Outcomes in Your Clinical Practice?

This game-based activity highlights how to diagnose, treat, and/or manage patients with chronic spontaneous urticaria in their patients. The goals of the program are to enhance the clinician’s ability to use clinical findings and molecular biomarkers to identify disease severity and predict response to treatment; design treatment regimens for patients with CSU who fail to respond to therapy; and select appropriate therapeutic options based on evaluation of emerging clinical trial data.

Learn More & View Event »

Seeing Beyond the Disease: Reducing the Burden of Neovascular Age-Related Macular Degeneration, Diabetic Macular Edema, and Diabetic Retinopathy Through Early Intervention

This online activity targets healthcare gaps correlated with early intervention in neovascular age-related macular degeneration (nAMD), diabetic macular edema (DME) and diabetic retinopathy (DR) without center-involved macular edema, which can have a profound impact on vision-related quality of life.

Release Date: February 19, 2021
Expiration Date: February 19, 2022

Learn More & View Event »

A Whiteboard View of the New Era in Alopecia Areata: The Role of JAK Inhibitors

This case-based activity targets healthcare gaps related to the underlying autoimmune causes of alopecia areata (AA) and targeted treatment approaches, which can have a profound impact on health-related quality of life through burden of disease and associated comorbidities. This content was co-created by Dr. Brett King (New Haven, CT) and Dr. Rodney Sinclair (Melbourne, Australia).

  • By addressing these gaps, you can assess whether your approach to AA management through utilization of immune-related targeted treatment approaches and comorbidity assessment – could be modified to help close these gaps.
  • Expert discussion will guide you in analyzing and identifying appropriate candidates for immune-targeted treatment of alopecia with JAK inhibitors, as well as assessment and management strategies for associated comorbidities.
  • You will also be immersed in dynamic animations utilizing a whiteboard platform to memorably highlight key points related to immune pathways in the development of alopecia areata and patient counseling techniques for tailored disease and comorbidity management.

Release Date: February 25, 2021
Expiration Date: February 25, 2022

Learn More & View Event »

COVID-19 Frontline – A New Light in the Darkness: Therapies Recently Granted Emergency Use Authorizations for Patients with COVID-19

The COVID-19 FRONTLINE TeleECHO program provides a comprehensive and up-to-date perspective on the ever-changing management of patients with COVID-19. This recorded TeleECHO session features in-depth case studies to encourage retention of the lessons and provide new perspectives on the management of patients during the COVID-19 pandemic. The case studies will focus on different issues facing clinicians, such as identifying patients who would benefit from monoclonal antibody therapy and best practices for incorporating agents authorized for emergency use into the care of hospitalized and non-hospitalized patients with COVID-19.

Release Date: March 4, 2021
Expiration Date: March 4, 2022

Learn More & View Event »

Seeing Clearer: Optimizing the Use of Vascular Endothelial Growth Factor Inhibitors in Diabetic Retinopathy
Immersive Simulation Experience

The diabetic retinopathy (DR) Immersive Simulation Experience allows learners to engage in clinical decision-making targeting diagnosis and therapeutic approaches in DR management. By participating in this simulated 3D encounter, you will observe patient-provider interactions and use pertinent information from the patients’ electronic chart to decide the next best course of action at various key points in care. Highlighted areas for this activity include assessment of retinopathy severity, intensification of treatment, as well as the recognition and management of adverse events.

Release Date: March 18, 2021
Expiration Date: March 18, 2022

Learn More & View Event »

The RELIEF Initiative
Managing Psoriatic Arthritis in Specialty Practice: New Therapies, Guidelines and Treatment Targets During the COVID-19 Pandemic

This situation room activity allows learners to practice making clinical decisions in the management of patients with psoriatic arthritis. Learners will view a simulated interaction between a patient and their physician and use information from the patient’s electronic chart to decide the next best course of action. Topics covered in this activity include assessment of disease severity, treatment selection, and managing patients with SARS-CoV-2 infection or exposure.

Release Date: March 18, 2021
Expiration Date: March 18, 2022

Learn More & View Event »

Managing Toxicities Associated with HER2-Targeted Therapy: Focus on Pulmonary Events

This activity will allow clinicians to recognize the symptoms of interstitial lung disease, a potentially serious pulmonary toxicity associated with several HER2-targeted therapies for the treatment of cancer. Learners will be able to recognize the signs and symptoms of pulmonary toxicity associated with systemic cancer therapy including interstitial lung disease and pneumonitis.

Release Date: March 30, 2021
Expiration Date: March 30, 2022

Learn More & View Event »

ECHO Series: Timely Recognition, Management, and Referral of Axial Spondyloarthritis

The AxSpA TeleECHO enduring will explore strategies to promptly recognize, diagnose, and manage patients with axial spondyloarthritis (AxSpA). This program provides an interactive platform that includes didactic programming in addition to case-based discussion on the selection of therapeutic options and the management of patients with AxSpA.

Release Date: March 30, 2021
Expiration Date: March 30, 2022

Learn More & View Event »

Seeing Clearer: Optimizing the Use of Vascular Endothelial Growth Factor Inhibitors in Age-related Macular Degeneration
Immersive Simulation Experience

The Age-related Macular Degeneration (AMD) Immersive Simulation Experience allows learners to engage in clinical decision-making targeting diagnosis and therapeutic approaches in AMD management. By participating in this simulated 3D encounter, you will observe patient-provider interactions and use pertinent information from the patients’ electronic chart to decide the next best course of action at various key points in care. Highlighted areas for this activity include assessment of AMD classification, risk factor modification, interventions based on AMD classification, as well as the recognition and management of treatment-related adverse events.

Release Date: April 2, 2021
Expiration Date: April 2, 2022

Learn More & View Event »

Seeing Clearer: Optimizing the Use of Vascular Endothelial Growth Factor Inhibitors in Retinal Vein Occlusion
Immersive Simulation Experience

The Retinal Vein Occlusion (RVO) Immersive Simulation Experience allows learners to engage in clinical decision-making targeting diagnosis and therapeutic approaches in RVO management. By participating in this simulated 3D encounter, you will observe patient-provider interactions and use pertinent information from the patients’ electronic chart to decide the next best course of action at various key points in care. Highlighted areas for this activity include assessment of RVO classification, risk factor modification, interventions based on RVO classification, as well as the recognition and management of treatment-related adverse events.

Release Date: April 23, 2021
Expiration Date: April 23, 2022

Learn More & View Event »

A Light in the Darkness: New Virus-neutralizing Monoclonal Antibodies and Other Point-of-Care Therapies Recently Granted Emergency Use Authorization for Patients with COVID-19

The COVID-19 FRONTLINE TeleECHO session provides a comprehensive and up-to-date perspective on the ever-changing management of patients with COVID-19. This recording features in-depth case studies to encourage retention of the lessons and provide new perspectives on the management of patients during the COVID-19 pandemic. The case studies will focus on different issues facing clinicians, such as identifying patients who would benefit from monoclonal antibody therapy and best practices for incorporating agents authorized for emergency use into the care of hospitalized and non-hospitalized patients with COVID-19. Strategies for administering neutralizing monoclonal antibodies, such as referral to local infusion centers or developing in-clinic infusion capabilities, will also be discussed.

Release Date: May 3, 2021
Expiration Date: May 3, 2022

Learn More & View Event »

Please note that the program was recorded before nivolumab was approved on August 19, 2021, for the adjuvant treatment of people with urothelial carcinoma who are at high risk of recurrence after radical resection. The approval is supported by results of a randomized, double-blind, placebo-controlled trial showing a statistically significant improvement in disease free survival observed in both the intent-to-treat patient cohort and in those whose tumors express PD-L1 ≥1%. The results of the clinical trial supporting this approval also led to the conversion of nivolumab’s accelerated approval to regular approval in advanced/metastatic UC.

Immunotherapy of Bladder Cancer: Integrating New Biomarkers and Treatment Guidelines into Clinical Practice

This activity will cover the treatment and management of patients with bladder cancer.

Release Date: May 7, 2021
Expiration Date: May 7, 2022

Learn More & View Event »

Seeing Clearer: Optimizing the Use of Vascular Endothelial Growth Factor Inhibitors in Diabetic Retinopathy

This online activity targets healthcare gaps correlated with screening, multidisciplinary care and timely intervention in diabetic retinopathy (DR), which can impact vision-related quality of life.

  • By addressing these gaps, you can assess whether your approach to DR management through screening, utilization of clinical trial data to guide appropriate treatment, and multidisciplinary coordination for comprehensive DR management – could be modified to help both strategize treatment design and close these gaps.
  • Expert discussion will guide you in identifying appropriate opportunities for early intervention, as well as assessing the impact that DR can have on vision-related quality of life.
  • You will also be immersed in dynamic whiteboard animations to memorably highlight key points related to how the inflammatory and vascular endothelial growth factor (VEGF) pathways lead to the development of DR, as well as the fundoscopic retinal changes associated with each retinopathy stage.

Release Date: May 11, 2021
Expiration Date: May 11, 2022

Learn More & View Event »

A Light in the Darkness: New Virus-neutralizing Monoclonal Antibodies and Other Point-of-Care Therapies Recently Granted Emergency Use Authorizations for Patients with COVID-19

The COVID-19 FRONTLINE Grand Rounds series provides a comprehensive and up-to-date perspective on the ever-changing management of patients with COVID-19. Each Grand Rounds session features in-depth case studies to encourage retention of the lessons and provide new perspectives on the management of patients during the COVID-19 pandemic. This program will focus on optimizing outcomes for hospitalized and nonhospitalized patients with COVID-19 through the use of novel agents authorized for emergency use.

Release Date: May 11, 2021
Expiration Date: May 11, 2022

Learn More & View Event »

COVID-19 Frontline Initiative: Supporting Patient Journeys through Resources and Tools to Promote Positive Patient Outcomes in Care

COVID-19 FRONTLINE podcasts provide a comprehensive and up-to-date perspective on the ever-changing management and prevention of COVID-19. Each podcast focuses on different issues facing clinicians and patients, such as managing patients with COVID-19, addressing the care of special populations during the pandemic, and coping with the long road to recovery.

Release Date: May 28, 2021
Expiration Date: May 28, 2022

Learn More & View Event »

Seeing Clearer: Optimizing the Use of Vascular Endothelial Growth Factor Inhibitors in Age-related Macular Degeneration

This online activity targets healthcare gaps correlated with screening, multidisciplinary care and timely intervention in age-macular degeneration (AMD), which can impact vision-related quality of life.

  • By addressing these gaps, you can assess whether your approach to AMD management through screening, utilization of clinical trial data to guide appropriate treatment and multidisciplinary coordination for comprehensive AMD management – could be modified to help both strategize treatment design and close these gaps.
  • Expert discussion will guide you in identifying appropriate opportunities for early intervention, as well as assessing impact that AMD can have on vision-related quality of life.
  • You will also be immersed in dynamic whiteboard animations to memorably highlight key points related to how the inflammatory and vascular endothelial growth factor (VEGF) pathways lead to the development of AMD, as well as the fundoscopic retinal changes associated with each stage of AMD.

Release Date: May 28, 2021
Expiration Date: May 28, 2022

Learn More & View Event »

COVID-19 Frontline:
An Innovative View of Monoclonal Therapies and Vaccines for COVID-19: Educating Patients on the Mechanism of Action, Safety, and Efficacy of Emerging Agents
Vaccine Track

This program will explore the use of vaccines and monoclonal antibody therapies for the prevention and treatment of patients with COVID-19. Innovative virtual reality animations will delve into the mechanism of action of emerging vaccines and monoclonal antibodies, the rationale for early administration of monoclonal antibodies in recently infected and uninfected individuals, and compare active and passive immunity.

Release Date: June 2, 2021
Expiration Date: June 2, 2022

Learn More & View Event »

COVID-19 Frontline:
An Innovative View of Monoclonal Therapies and Vaccines for COVID-19: Educating Patients on the Mechanism of Action, Safety and Efficacy of Emerging Agents
Treatments Track

This program will explore the use of polyclonal and monoclonal antibody therapies for the treatment of patients with COVID-19. Innovative virtual reality animations will delve into the mechanism of action of antibody therapies, the impact of SARS-CoV-2 variants on treatment efficacy, and the role of dual monoclonal antibody cocktails in the prevention of viral escape.

Release Date: June 2, 2021
Expiration Date: June 2, 2022

Learn More & View Event »

Tackling COVID-19 and its Viral Variants on the Frontline with New Vaccines and Novel Monoclonal Antibody Treatments

This COVID-19 FRONTLINE Whiteboard Module will explore the role of emerging SARS-CoV-2 variants and their potential impact on the efficacy of current monoclonal antibody therapies and vaccines authorized for emergency use in managing the COVID-19 pandemic. We will focus on SARS-CoV-2 viral variants and emerging clinical data of their impact on vaccines and monoclonal antibodies currently authorized for emergency use. A whiteboard animation will be used to enhance the learning experience of this activity.

Release Date: June 2, 2021
Expiration Date: June 2, 2022

Learn More & View Event »

Tackling COVID-19 and its Viral Variants on the Frontline with New Vaccines and Novel Monoclonal Antibody Treatments

This COVID-19 Snapshot will explore the role of emerging SARS-CoV-2 variants and their potential impact on the efficacy of current monoclonal antibody therapies and vaccines authorized for emergency use in managing the COVID-19 pandemic.

In this module, we will discuss mutations in the spike protein of SARS-CoV-2 viral variants and the potential impact of these alterations on the efficacy of current vaccines and monoclonal antibodies authorized for emergency use management of the COVID-19 pandemic. We will also share resources and tools for the administration of monoclonal antibody infusion therapies, as well as programs and initiatives developed to improve the ease and access of diagnostic technologies across the United States.

Release Date: June 2, 2021
Expiration Date: June 2, 2022

Learn More & View Event »

Tap the 3 lines above to show the other categories

Quick Links

Useful Resources

  • Accreditation Council for Continuing Medical Education.
    Visit the ACCME website
  • Alliance for Continuing Education in the Health Professions.
    Visit the ACEHP website

Connect With Us

Facebook Linkedin Twitter Instagram Tiktok

Join Our Mailing List

Copyright © 2024 Med Learning Group. All rights reserved. Website by Divigner
Scroll to Top

A Special Thank You to All HCPs

Med Learning Group sends its heartful gratitude to all healthcare professionals giving their all, 24/7, during this pandemic, despite the great risks they face. We cannot thank you enough for your courage and selfless service.

Connecting you with our personalized approach to continuing Medical Education

Learn more

Healthcare Business Review Award

We are thrilled to announce that we have been recognized as one of the Top 10 Health Education Services Providers by Healthcare Business Review!

This award is both an honor and a testament to our cumulative dedication to providing the best continuing medical education (CME) services to HCPs across the globe. We are proud to be part of this distinguished group and look forward to continuing to have MLG be one of the best CME providers in the country.

Thank you to Healthcare Business Review for this recognition and for shining a light on the importance of accurate and accessible healthcare education.

#TopHealthEducationProvider #MedLearningGroup #HealthcareBusinessReview #MedicalEducation
Read Full Article
BestofAmerica

Best of America Small Business Awards
Best Website

The Best of America Small Business Website award recognizes the best website launched by a small business since 2021. Technology is a key growth enabler for small businesses. The best in tech track recognizes small businesses as experts in technology and innovation from innovators, app developers, and website creators. Visit our award-winning Ophthalmology and Optometry web portal: vision-relief.com

The Linking Approach to Education from Gap Analysis to Outcomes

Med Learning Group, a division of Ultimate Medical Academy, is a full-service accredited medical education company with commendation. Med Learning Group focuses on developing and implementing continuing education that improves healthcare practitioners’ ability to provide optimal care to their patients. Our goal is to provide high-quality education that is designed to deliver the highest level of outcomes for not only the practitioner, but also the patient. Med Learning Group has expertise in developing both live and online activities that are innovative, case-based, interactive and patient-centric in nature.

Med Learning Group has expertise in developing both live and online activities that are innovative, case-based, interactive and patient-centric in nature, and we focus on applying adult learning theory and principles to our programs. Even more importantly, we understand the nuances of our target audiences and design programs with a grounded understanding of how to educate both specialty audiences and general practitioners.

CME Programs

Med Learning Group has a wide array of CME programs available to the medical community; live summit meetings, online cme, grand rounds, and simulcasts.
Browse CME

White Papers

Med Learning Group is highly respected in the CME industry and have published several Whitepapers on various topics.
View Publications

Awards & Recognition

Med Learning Group has been the recipient of several awards for its innovative technology and development of cutting edge CME initiatives.
View Awards

Testimonials

Med Learning Group is committed to meeting all the needs of the learners we educate and the faculty who teach them.
View Testimonials